Cronos Group Inc. (CRON) — Stock Score Summary

Cronos Group Inc. (CRON) has a MoatMap StockRank of 79/100 based on Quality (53/100), Value (45/100), and Momentum (65/100) factor scores. The current signal is BUY. Cronos Group operates in the highly speculative and structurally unprofitable cannabis sector. It lacks pricing power, a durable moat, and any alignment with our core macro themes.

Cronos Group Inc. is a global cannabinoid company engaged in the cultivation, production, and marketing of cannabis and hemp-derived products for medical and recreational markets. A significant strategic investment and partnership with Altria Group provides a strong competitive moat through enhanced capital, distribution channels, and research capabilities, positioning it for leadership in the evolving cannabis industry.

Key Financial Metrics

Price$2.79
Market Cap$1.1B
P/E (Forward)-70.00
Price/Book0.98
Return on Equity0.5%
Return on Invested Capital-1.7%
Debt/Equity0.12
Gross Margin39.6%
Operating Margin-1.1%
Revenue Growth40.1%
Free Cash Flow$-15M

Cronos Group Inc. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (Canada).

Frequently Asked Questions

What is Cronos Group Inc.’s (CRON) StockRank?
MoatMap’s StockRank for Cronos Group Inc. (CRON) is 79/100, with a Buy signal. It is a composite of Quality (53), Value (45), and Momentum (65) factor ranks across MoatMap’s 19,000+ stock universe.
Does Cronos Group Inc. have an economic moat?
Cronos Group Inc. (CRON) has a Quality factor score of 53/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Cronos Group Inc. a buy, hold, or sell?
MoatMap’s current signal for Cronos Group Inc. (CRON) is Buy, based on a StockRank of 79/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Cronos Group Inc. in?
Cronos Group Inc. (CRON) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (Canada).
Browse all ranked stocksCRON deep dive reportAI ChampionsHow we score stocksSense-check another stock